Jon Marc Wigginton

Leeftijd : 60

Belangrijkste bedrijven :

Overzicht

Currently, Jon Marc Wigginton occupies the position of President-Research & Development at Bright Peak Therapeutics AG. Dr. Wigginton is also on the board of Sutro Biopharma, Inc., UbiVac, Inc. and Kalivir Immunotherapeutics.

Dr. Wigginton previously was Chief Medical Officer & SVP-Clinical Development at MacroGenics, Inc., Chairman-SAB at Cullinan Oncology, Inc. and Chief Medical Officer of Cullinan Oncology LLC (a subsidiary of Cullinan Oncology, Inc.), Executive Director-Discovery Medicine-Clinical at Bristol Myers Squibb Co., Head-Investigational Biologics Section at Center for Cancer Research, Director-Clinical Oncology at Merck Research Laboratories Massachusetts LLC and President at Society For Immunotherapy of Cancer.

Dr. Wigginton received a doctorate and an undergraduate degree from the University of Michigan.

Posities en verantwoordelijkheden van Jon Marc Wigginton

Naam	Titel	Van
Sutro Biopharma, Inc. (Biotechnologie & Medisch Onderzoek)	Independent Director	2020
Bright Peak Therapeutics AG	President-Research & Development	-
UbiVac, Inc.	Director	2020
Kalivir Immunotherapeutics, Inc.	Director	-

Belangnemingen van Jon Marc Wigginton

Naam	Aandelen	%	Totale waarde
Sutro Biopharma, Inc. (STRO) (Biotechnologie & Medisch Onderzoek)	0	0,0000%	0 USD

Jon Marc WiggintonPersoonlijk netwerk

Naam	Verwante bedrijven
Michael Dybbs	Sutro Biopharma, Inc.
Shabbir T. Anik	Sutro Biopharma, Inc.
Diana Landa	Sutro Biopharma, Inc.
Regina Cheng	Sutro Biopharma, Inc.
Craig Berman	Sutro Biopharma, Inc.
Anne E Borgman	Sutro Biopharma, Inc.
Connie Matsui	Sutro Biopharma, Inc.
Nicki Vasquez	Sutro Biopharma, Inc.
Brunilda Shtylla	Sutro Biopharma, Inc.
Heidi Hunter	Sutro Biopharma, Inc.